Fortress Biotech, Inc. - 9.375% - stock earnings
FBIOP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -5.0 million USD | 34.8 million USD |
| 2023Q2 | -24.8 million USD | 17.4 million USD |
| 2023Q1 | -22.1 million USD | 12.4 million USD |
| 2022Q4 | -57.4 million USD | 16.4 million USD |
| 2022Q3 | -17.6 million USD | 16.5 million USD |
| 2022Q2 | -16.7 million USD | 18.9 million USD |
| 2022Q1 | -9.8 million USD | 23.9 million USD |
| 2021Q4 | -31.6 million USD | 18.3 million USD |
| 2021Q3 | -20.8 million USD | 21.1 million USD |
| 2021Q2 | -3.5 million USD | 17.8 million USD |
| 2021Q1 | -8.8 million USD | 11.6 million USD |
| 2020Q4 | -5.3 million USD | 13.7 million USD |
| 2020Q3 | -15.5 million USD | 9.5 million USD |
| 2020Q2 | -13.3 million USD | 9.5 million USD |
| 2020Q1 | -12.4 million USD | 12.9 million USD |
| 2019Q4 | -15.5 million USD | 11.1 million USD |
| 2019Q3 | -12.8 million USD | 9.8 million USD |
| 2019Q2 | -13.1 million USD | 9.3 million USD |
| 2019Q1 | 1.4 million USD | 6.5 million USD |
| 2018Q4 | -24.9 million USD | -156.1 million USD |
| 2018Q3 | -16.6 million USD | 63.7 million USD |
| 2018Q2 | -21.6 million USD | 63.8 million USD |
| 2018Q1 | -21.0 million USD | 55.4 million USD |
| 2017Q4 | -10.4 million USD | 45.3 million USD |
| 2017Q3 | -27.1 million USD | 46.9 million USD |
| 2017Q2 | -17.4 million USD | 50.7 million USD |
| 2017Q1 | -12.0 million USD | 44.7 million USD |
| 2016Q4 | -17.4 million USD | 12.6 million USD |
| 2016Q3 | -13.0 million USD | 975000 USD |
| 2016Q2 | -12.5 million USD | 2.2 million USD |
| 2016Q1 | -12.2 million USD | 660000 USD |
| 2015Q4 | -12.0 million USD | 338000 USD |
| 2015Q3 | -18.2 million USD | 25000 USD |
| 2015Q2 | -6.2 million USD | ? USD |
| 2015Q1 | -12.1 million USD | 500000 USD |
| 2014Q4 | -3.7 million USD | ? USD |
| 2014Q3 | -4.6 million USD | ? USD |
| 2014Q2 | -4.7 million USD | ? USD |
| 2014Q1 | -7.4 million USD | ? USD |
| 2013Q4 | -9.8 million USD | ? USD |
| 2013Q3 | -7.8 million USD | ? USD |
| 2013Q2 | -10.7 million USD | ? USD |
| 2013Q1 | -8.9 million USD | ? USD |
| 2012Q4 | -8.7 million USD | ? USD |
| 2012Q3 | -5.9 million USD | ? USD |
| 2012Q2 | -6.5 million USD | ? USD |
| 2012Q1 | -6.6 million USD | ? USD |
| 2011Q4 | -6.7 million USD | ? USD |
| 2011Q3 | -3.4 million USD | ? USD |
| 2011Q2 | -3.7 million USD | ? USD |
| 2011Q1 | -22.5 million USD | ? USD |
| 2010Q4 | -1.6 million USD | ? USD |
| 2010Q3 | -2.1 million USD | ? USD |
FBIOP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -78.3 million USD | 81.0 million USD |
| 2022 | -213.9 million USD | 75.7 million USD |
| 2021 | -164.8 million USD | 68.8 million USD |
| 2020 | -103.0 million USD | 45.6 million USD |
| 2019 | -51.8 million USD | 36.6 million USD |
| 2018 | -84.1 million USD | 26.9 million USD |
| 2017 | -66.9 million USD | 187.6 million USD |
| 2016 | -55.1 million USD | 16.5 million USD |
| 2015 | -48.4 million USD | 863000 USD |
| 2014 | -20.4 million USD | ? USD |
| 2013 | -37.2 million USD | ? USD |
| 2012 | -27.6 million USD | ? USD |
| 2011 | -36.4 million USD | ? USD |
| 2010 | -10.0 million USD | ? USD |
FBIOP
Price: $13.82
52 week price:
5-year range yield:
Forward Dividend Yield: 16.96%
Payout Ratio: -271.58%
Payout Ratio Range:
Dividend Per Share: 2.34 USD
Earnings Per Share: -0.86 USD
P/E Ratio: -15.64
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 15415
Market Capitalization: 93.9 million
Average Dividend Frequency: 9
Years Paying Dividends: 8